Deerfield Management’s Apyx Medical APYX Stock Holding History

Deerfield Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-688,229	Closed	-$1.45M	–	106
2015 Q4	$1.45M	Hold	688,229	–	–	0.06%	102
2015 Q3	$1.34M	Hold	688,229	–	–	0.05%	121
2015 Q2	$1.92M	Sell	688,229 -11,771	-2%	-$32.4K	0.06%	107
2015 Q1	$1.67M	Buy	+700,000	New	+$2.33M	0.05%	103

Other funds holding APYX

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deerfield Management's APYX Position: Q1 2016 in Review

Deerfield Management sold out of Apyx Medical (APYX) in Q1 2016, closing a stake of 688,229 shares — an estimated $1.45M sold.

Deerfield Management first reported a position in APYX in Q1 2015 and held it in 4 quarters. The position peaked at $1.92M in Q2 2015. 31 funds tracked by Wall St. Rank hold APYX as of Q1 2016.

Deerfield Management reported no remaining Apyx Medical position as of Q1 2016 after selling out during the quarter.
Deerfield Management sold 688,229 Apyx Medical shares in Q1 2016, an estimated $1.45M.
Deerfield Management first reported a position in Apyx Medical in Q1 2015 and held it in 4 quarters.
Deerfield Management's Apyx Medical position peaked at $1.92M in Q2 2015.
31 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2016.

Based on Deerfield Management's 13F filing for Q1 2016, filed 16 May 2016.